long term comparing IV vs subcutaneous trastuzumab
Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients’ With HER2-Positive Metastatic Breast Cancer
https://www.clinical-breast-cancer.c...164-7/fulltext
|